TALENCE, France

Warter Elise

This inventor holds 1 USPTO granted patent. Top assignee: Treefrog Therapeutics. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Warter Elise. Retrieved from https://idiyas.com/inventor/warter-elise

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Warter Elise and Cellular Microcompartment Innovation.

Introduction

Warter Elise is an inventor based in Talence, France, associated with Treefrog Therapeutics. His patent work focuses on cellular microcompartments designed to support the production of cells and tissues for potential clinical applications.

Latest Patents

Elise is named on 1 patent: “Extracellular matrix substitute in a cellular microcompartment.” The invention describes a microcompartment containing at least one layer of cells, an outer hydrogel layer, and a fibrin mesh positioned between them. The design is described as compliant with Good Manufacturing Practices (GMP) and suitable for clinical applications. The patent also covers methods for preparing the microcompartment and using it to produce cells and tissues, including at large scale.

Career Highlights

Elise’s listed patent reflects work on cellular manufacturing technologies intended to bridge laboratory processes and clinical production. His association with Treefrog Therapeutics connects this work to the company’s focus on cell-based technologies.

Collaborations

The provided information identifies Clément Rieu and Joffrey Mianné as Elise’s coworkers. Their names are associated with his professional context, though specific roles in the patent are not stated.

Conclusion

Warter Elise’s patent centers on a GMP-compliant cellular microcompartment that combines cells, hydrogel, and fibrin mesh to support the preparation and scalable production of cells and tissues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…